Beruflich Dokumente
Kultur Dokumente
• • • • • •
• • • • • • 323
Tableau II. Définition du syndrome
métabolique du NCEP/ATP III [12]
Anneau de Kayser-Fleischer 23 %
Céruléoplasmine 23 %
Les 2 à la fois 18 %
Cuprurie 14 %
Les 3 à la fois 14 %
Âge > 40 ans 3,8 %
324 • • • • • •
était trouvée chez 3,4 % des patients. 5. Pendino GM, Mariano A, Surace P, 10. Bianchi L. Liver biopsy in elevated
Dans l’étude nord-américaine, la biop- Caserta CA, Fiorillo MT, Amante A, et liver functions tests? An oldd ques-
sie du foie permettait de modifier la al. Prevalence and etiology of altered tion revisited. J Hepatol 2001; 35:
prise en charge des patients dans 18 % liver tests: a population-based survey 290-4.
in a Mediterranean town. Hepatology
des cas [11]. 11. Skelly MM, James PD, Ryder SD.
2005;41:1151-9.
Findings on liver biopsy to investigate
6. Ruhl CE, Everhart J. Elevated serum abnormal liver function tests in the
alanine aminotransferase and -glu- absence of diagnostic serology. J
tamyltransferase and mortality in the Hepatol 2001;35:195-9.
Références United States population.
12. Expert Panel on Detection, Evaluation,
Gastroenterology 2009;136:477-85.
and Treatment of High Blood
1. Valla DC. Augmentation chronique 7. De Ledinghen V, Ratziu V, Causse X,
Cholesterol in Adults Executive
inexpliquée des transaminases. Le Bail B, Capron D, Renou C, et al.
Summary of the Third Report of the
Hépato-Gastro 2003;10:257-63. Diagnostic and predictive factors of
National Cholesterol Education
significant liver fibrosis and minimal
2. Pratt DS, Kaplan MM. Evaluation of Program (NCEP) Expert Panel on
lesions in patients with persistent
abnormal liver enzyme results in Detection, Evaluation, and Treatment
unexplained elevated transaminases.
asymptomatic patients. N Engl J Med of High Blood Cholesterol in Adults
A prospective multicenter study. J
2000;342:1266-71. (Adult Treatment Panel III). JAMA
Hepatol 2006;45:592-9.
2001;285(19):2486-97.
3. Lazo M, Selvin E, Lark JM. Clinical 8. Barbare JC. Élévation chronique des
implications of short-term variability transaminases : que faire quand on n’a 13. Gow PJ, Smallwood RA, Angus PW,
in liver function test results. Ann rien trouvé ? Post’U 2004:31-46. Smith AL, Wall AJ, Sewell RB.
Intern Med 2008;148:348-52. Diagnosis of Wilson’s disease: an
9. Hanachi M, Melchior JC, Crenn P.
experience over three decades. Gut
4. Clark JM, Brancati FL, Diehl AM. The Hypertransaminasemia in severely
2000;46:415-9.
prevalence and etiology of elevated malnourished adult anorexia nervosa
aminotransferase levels in the United patients. Risk factors and evolution 14. Ferenci et al. Late-Onset Wilson’s
States. Am J Gastroenterol 2003;98: under enteral nutrition. Clin Nutr Disease. Gastroenterology Vol. 132,
960-7. 2012; (in press). No. 4.
• • • • • • 325